Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: a pilot, open-label study
Produto dispensado de registro conforme RDC ANVISA 240/2018 !conteudo= !item= =item
doi: 10.3389/fnut.2022.851275 Received 09 January 2022 Accepted 21 July 2022 Published 10 August 2022 Volume 9 - 2022 Edited by Alessandra Durazzo, Council for Agricultural Research and Economics, Italy Reviewed by Mohd Ashraf Ganie, Sher-I-Kashmir Institute of Medical Sciences, India
A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma
Although the findings are not always consistent, changes in the brainstem have been very common, especially structural changes, mainly a decrease in grey or white matter volume in patients, often pronounced in relation to the symptom burden of fatigue, pain and autonomic symptoms